Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Recent News
今後の臨床試験
-
NCT04593316まだ募集していない条件：Heat Stroke
-
NCT04593329まだ募集していない条件：Acute Pain
-
NCT04593368まだ募集していない条件：Antibiotic Resistant Strain
-
NCT04593381まだ募集していない条件：Ovarian Cancer; Oligometastatic Disease; Recurrent Ovary Cancer; Persistent
-
NCT04593394まだ募集していない条件：Asthma Chronic; Exercise-Induced Vocal Cord Dysfunction
-
NCT04593407まだ募集していない条件：Neoplasms, Colorectal
-
NCT04593420まだ募集していない条件：Prostate Cancer
-
NCT04593433まだ募集していない条件：Social Isolation; Quality of Life; Well Aging; Frailty
-
NCT04593446採用条件：Colorectal Cancer
-
NCT04593498まだ募集していない条件：Atrial Fibrillation; Atrial Flutter; Supraventricular Beat, Premature; Premature Supraventricular Beats; Premature Atrial Complex; Extrasystole, Atrial
Recent CRA jobs
-
IT Project/Release Manager
-
QC Reviewer- Vaccine Lab
-
Medical Information Specialist -German Speaking, Sofia,Bulgaria
-
Associate Medical Director (Haematology) EMEA
-
Site Activation Coordinator - Paris, France
-
Sr Biostatistician I/II - Europe
-
Coding Specialist (Smolensk, Russia)
-
Sr QA Specialist
-
Central Review Mgr
-
Feasibility Strategist - Clinical Trials (all levels - remote EMEA)